US Patent Issued to Medtronic on Oct. 6 for "Neuromodulation for treatment of neonatal chronic hyperinsulinism" (Minnesota, California, Texas Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,115, issued on Oct. 6, was assigned to Medtronic Inc. (Minneapolis).

"Neuromodulation for treatment of neonatal chronic hyperinsulinism" was invented by Maneesh Shrivastav (Blaine, Minn.), Shaileshkumar V. Musley (Brooklyn Park, Minn.), Kanthaiah Koka (Valencia, Calif.), Steven M. Goetz (North Oaks, Minn.), Suryakiran Vadrevu (Santa Clarita, Calif.), Rebecca K. Gottlieb (Culver City, Calif.), David John Miller (Austin, Texas) and Leonid M. Litvak (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "A system is provided herein for stimulating an anatomical element of a patient to regulate insulin production of the patient. In some examples, the...